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Esophageal squamous cell carcinoma (ESCC) is
one of the most prevalent malignant tumors 
in developing countries, especially in China. Al-
though treatment strategies continue to improve,
ESCC cells have been known to develop resistance
to chemoradiotherapy, resulting in a dramatic de-
crease in the 5-year survival rate.1 Evasion of apo-
ptosis is also recognized to result in resistance to
anticancer therapies. However, some evidence has
indicated that chemotherapeutic agents not only
kill cells through induction of apoptosis, but also
by non-apoptotic forms of cell death.2 Although
the significance of non-apoptotic cell death in
chemotherapy and the mechanisms by which it
is induced remain unclear, there has been consid-
erable progress in our thinking that autophagy
might play an important role in resistance to
therapy of ESCC cells.
Autophagy is an evolutionarily highly con-
versed process among all eukaryotes ranging from
yeast to mammals. The functional relationship be-
tween autophagy and cellular death or survival is
complicated in that, in several situations, auto-
phagy promotes survival under conditions of stress
and starvation, whereas in other cellular situa-
tions, autophagy constitutes an alternative path-
way to cellular demise (autophagic cell death).
Via performance of homeostatic functions, auto-
phagy can work as a cellular housekeeper to re-
spond to metabolic stress, including eliminating
excessive or unnecessary proteins and injured or
aged organelles.3 Therefore, autophagy may be
viewed as a new potential survival mechanism in
normal and tumor cells.
Background and Evidence
Many studies have indicated that autophagy plays
a role as a survival mechanism and has a special
housekeeping role in the turnover of cytoplasmic
constituents, including mitochondria.3 Moreover,
autophagy might prevent aggregate formation by
degradation of proteins such as monomers and
oligomers.
Although autophagy has been induced in many
different cancer cell lines including esophageal
cancer cells,4 the role of autophagy in regulating
tumor cell death or survival remains unclear.
Autophagy has several implications in human dis-
orders and tumors, and can act as a cellular de-
fense mechanism. Thus, it could play an important
role in the mechanism by which tumor cells try
to maintain survival.
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In fact, many researchers have found that 
autophagy allows tumor cells to survive under che-
moradiotherapy. In human colon cancer cells, in-
hibition of autophagy can augment 5-fluorouracil
chemotherapy.5 Moreover, inhibition of auto-
phagy induced by overexpression of melanoma
differentiation-associated gene 7 (interleukin-
24) can strongly augment antileukemia activity.6
Besides, many results have shown that inhibition
of autophagy can enhance tumor cell death via
apoptosis, which indicates that autophagy exerts
a protective role on tumor cell survival.
Moreover, other studies have proven that
tumor resistance to death can be enhanced through
upregulation of autophagy in different tumor cell
lines. Hypoxia-induced autophagy can decrease
hepatoma cell sensitization to chemotherapeutic
agents that affect their apoptotic potential.7 In
breast cancer cells, autophagy activated by eu-
karyotic elongation factor-2 kinase also plays a
protective role in cancer cells under metabolic
stress.8 Thus, many experiments have suggested
that induction of autophagy can help tumor cells
to survive and resist to anticancer therapy.
Previous studies have shown that inhibition
of autophagy can enhance the effects of apoptosis
induced by chemotherapeutic agents in esopha-
geal cancer cells.9,10 Therefore, we speculate that
autophagy plays a role in ESCC as a survival
pathway of treatment resistance.
Conclusion
In recent years, increasing attention has been fo-
cused on the role of autophagy in tumor cells.
Although a consensus has not yet been reached
regarding the role of autophagy in tumor cells,
and more studies are needed to prove the impact
of autophagy on ESCC, at least it provides us with
a new direction to explore the mechanisms of
treatment resistance of ESCC.
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